|
Antigen Specific T Cell tolerance by Anti CD3 Antibodies
|
9R01CA132197-06A2
|
$361,592
|
$361,592
|
ANASETTI, CLAUDIO
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
PROSTATE, LUNG, COLORECTAL AND OVARIAN (PLCO) CANCER SCREENING TRIAL - SCREENING
|
N01CN025516-089
|
$1,929,112
|
$385,822
|
ANDRIOLE, GERALD
|
WASHINGTON UNIV:1107522
|
|
Biologic Therapy for B-cell non-Hodgkin's Lymphoma
|
2R01CA092104-05A2
|
$258,741
|
$129,371
|
ANSELL, STEPHEN
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
EGFR antisense DNA added to cetuximab and radiotherapy for head and neck cancer
|
1R21CA130241-01A1
|
$330,678
|
$330,678
|
ARGIRIS, ATHANASSIOS
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
DF/HCC Renal Cancer SPORE
|
3P50CA101942-05S1
|
$1,165,299
|
$233,060
|
ATKINS, MICHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Southeast Cancer Control Consortium, Inc
|
5U10CA045808-22
|
$1,906,536
|
$19,065
|
ATKINS, JAMES
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
Purification of a Novel Antibody Against Solid Organ Cancer Stem Cells
|
Z01 BC 010997
|
$178,059
|
$178,059
|
Avital, Itzhak
|
CCR (NCI)
|
|
SOUTHWEST ONCOLOGY GROUP - OPERATIONS OFFICE
|
3U10CA032102-29S1
|
$628
|
$38
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
CCOP Research Base, PCPT/PCPT LTFU, and SELECT Programs
|
3U10CA037429-24S1
|
$464,405
|
$13,932
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Southwest Oncology Group
|
5U10CA027057-29
|
$262,397
|
$15,744
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
SOUTHWEST ONCOLOGY GROUP - OPERATIONS OFFICE
|
5U10CA032102-29
|
$9,490,764
|
$569,446
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
CCOP Research Base, PCPT/PCPT LTFU, and SELECT Programs
|
7U10CA037429-24
|
$16,768,272
|
$503,048
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Therapeutic Studies of Primary CNS Malignancies-NABTT
|
5U01CA105706-05
|
$70,948
|
$709
|
BARNETT, GENE
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
NABTT-New Approaches to Brain Tumor Therapy (CNSC)
|
5U01CA062406-14
|
$57,838
|
$578
|
Batchelor, Tracy
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA035119-24
|
$1,880,470
|
$18,805
|
BEARDEN, JAMES
|
SPARTANBURG REGIONAL MEDICAL CENTER
|
|
The Gulf Coast MBCCOP
|
7U10CA128536-02
|
$539,869
|
$5,399
|
BEEKER, THADDEUS
|
PROVIDENCE HOSPITAL (MOBILE, AL)
|
|
Rituximab Elicitation of Tumor Specific T-cell Responses in Lymphoma Patients
|
1R01CA122645-01A1
|
$329,408
|
$329,408
|
BERNSTEIN, STEVEN
|
UNIVERSITY OF ROCHESTER
|
|
Pediaric Oncology Research Training Program
|
5T32CA009351-30
|
$237,038
|
$35,556
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
SPORE in Brain Cancer
|
5P50CA108786-05
|
$74,190
|
$18,548
|
BIGNER, DARELL
|
DUKE UNIVERSITY
|
|
MSKCC Center for Molecular Imaging in Cancer
|
5P50CA086438-08
|
$1,904,290
|
$95,215
|
Blasberg, Ronald
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Regulation of Membrane Fusion by Viral and Cellular Proteins and Lipids
|
Z01 BC 008303
|
$330,989
|
$16,549
|
Blumenthal, Robert
|
CCR (NCI)
|
|
Lipid-based Nanocapsules and Nano Fusion Machines
|
Z01 BC 010652
|
$388,552
|
$38,855
|
Blumenthal, Robert
|
CCR (NCI)
|
|
Metal Chelate Conjugated Monoclonal Antibodies for Tumor Diagnosis and Therapy
|
Z01 SC 006353
|
$610,988
|
$610,988
|
Brechbiel, Martin
|
CCR (NCI)
|
|
Metal Chelate Conjugated Dendrimer Constructs for Diagnosis and Therapy
|
Z01 SC 010051
|
$328,993
|
$98,698
|
Brechbiel, Martin
|
CCR (NCI)
|
|
NEW APPROACHES TO BRAIN TUMOR THERAPY-(NABTT)
|
5U01CA062474-14
|
$119,036
|
$1,190
|
BREM, HENRY
|
JOHNS HOPKINS UNIVERSITY
|
|
Great Lakes/New England Clinical Epidemiology/Validation
|
5U01CA086400-09
|
$1,145,611
|
$114,561
|
Brenner, Dean
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Southwest Oncology Group
|
5U10CA004919-49
|
$192,303
|
$11,538
|
BUDD, G
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
PROSTATE, LUNG, COLORECTAL AND OVARIAN (PLCO) CANCER SCREENING TRIAL - SCREENI
|
N01CN025524-071
|
$1,294,530
|
$258,906
|
BUYS, SAUNDRA
|
UTAH UNIV:1109883
|
|
Cetuximab for Treatment of High-risk Pre-malignant Upper Aerodigestive Lesions
|
1R21CA126055-01A1
|
$369,000
|
$369,000
|
CALIFANO, JOSEPH
|
JOHNS HOPKINS UNIVERSITY
|
|
Innate Immunity: Elucidation and Modulation for Cancer Therapy
|
5P01CA095426-07
|
$2,003,446
|
$1,502,585
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
A randomized phase II study of erlotinib with or without the anti-IGF-1R monoclon
|
1R21CA135595-01
|
$369,078
|
$369,078
|
Camidge, Ross
|
UNIVERSITY OF COLORADO DENVER
|
|
Cancer Research for the Ozarks
|
5U10CA045560-20
|
$681,391
|
$6,814
|
CAROLLA, ROBERT
|
OZARK HEALTH VENTURES, LLC
|
|
A program of immune-based treatments for cancer
|
2K24CA093670-06
|
$178,300
|
$89,150
|
CARSON, WILLIAM
|
OHIO STATE UNIVERSITY
|
|
Molecular Signatures to Improve Diagnosis and Outcome Pr
|
5U01CA114778-04
|
$1,674,031
|
$418,508
|
Chan, Wing
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
Experimental Therapy of Cancer by Costimulated Immunity
|
5R01CA085721-09
|
$325,256
|
$97,577
|
Chen, Lieping
|
JOHNS HOPKINS UNIVERSITY
|
|
CD137 Antibody for Cancer Therapy
|
5R01CA106861-06
|
$317,808
|
$317,808
|
Chen, Lieping
|
JOHNS HOPKINS UNIVERSITY
|
|
PROSTATE, LUNG, COLORECTAL, AND OVARIAN (PLCO) CANCER SCREENING TRIAL - LABORAT
|
N01CN025404-039
|
$1,654,777
|
$330,955
|
CHIA, DAVID
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
HAWAII MINORITY-BASED CCOP
|
3U10CA063844-15S1
|
$100,000
|
$1,000
|
Cho, Jonathan
|
UNIVERSITY OF HAWAII AT MANOA
|
|
HAWAII MINORITY-BASED CCOP
|
5U10CA063844-15
|
$778,279
|
$7,783
|
Cho, Jonathan
|
UNIVERSITY OF HAWAII AT MANOA
|
|
Growth Factor Imaging
|
Z01 BC 010656
|
$660,446
|
$132,089
|
Choyke, Peter
|
CCR (NCI)
|
|
Angiogenesis imaging
|
Z01 BC 010714
|
$440,297
|
$44,030
|
Choyke, Peter
|
CCR (NCI)
|
|
PROSTATE, LUNG, COLORECTAL AND OVARIAN (PLCO) CANCER SCREENING TRIAL - SCREENI
|
N01CN025513-088
|
$1,561,211
|
$312,242
|
CHURCH, TIMOTHY
|
REGENTS OF THE UNIVERSITY OF MINNESOTA
|
|
Consortium Therapeutic Studies of Primary Central Nervous System Malignancies
|
5U01CA105695-05
|
$146,647
|
$1,466
|
CLOUGHESY, TIMOTHY
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
SPORE in Gl Cancer
|
5P50CA095103-07
|
$2,278,307
|
$569,577
|
COFFEY, ROBERT
|
VANDERBILT UNIVERSITY
|
|
Northwest Community Clinical Oncology Program
|
2U10CA035281-25
|
$691,655
|
$6,917
|
COLMAN, LAUREN
|
TACOMA GENERAL HOSPITAL
|
|
Microarray Platform for Profiling Cancer Proteases
|
5R33CA118696-03
|
$368,009
|
$92,002
|
CRAVATT, BENJAMIN
|
SCRIPPS RESEARCH INSTITUTE
|
|
PROSTATE, LUNG, COLORECTAL AND OVARIAN (PLCO) CANCER SCREENING TRIAL - SCREENI
|
N01CN025514-076
|
$1,436,604
|
$287,321
|
CRAWFORD, DAVID
|
University Of Colorado Health Sciences C
|
|
Southwest Oncology Group Statistical Center
|
3U10CA038926-23S1
|
$90,610
|
$5,437
|
CROWLEY, JOHN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Southwest Oncology Group Statistical Center
|
5U10CA038926-23
|
$4,459,748
|
$267,585
|
CROWLEY, JOHN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Community Clinical Oncology Program
|
5U10CA035431-25
|
$1,923,566
|
$19,236
|
DAKHIL, SHAKER
|
VIA CHRISTI REGIONAL MEDICAL CENTER
|
Total relevant funding to Monoclonal Antibodies for this search: $43,388,843
|